BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19596947)

  • 1. Preoperative leukocytosis, anemia and thrombocytosis are associated with poor survival in non-small cell lung cancer.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Anticancer Res; 2009 Jul; 29(7):2687-90. PubMed ID: 19596947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of thrombocytosis in resectable non-small cell lung cancer.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):613-5. PubMed ID: 18502783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Anticancer Res; 2008; 28(3B):1947-50. PubMed ID: 18630486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for patients with spinal metastases from lung cancer.
    Ogihara S; Seichi A; Hozumi T; Oka H; Ieki R; Nakamura K; Kondoh T
    Spine (Phila Pa 1976); 2006 Jun; 31(14):1585-90. PubMed ID: 16778693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum C-reactive protein level in non-small cell lung cancer.
    Hara M; Matsuzaki Y; Shimuzu T; Tomita M; Ayabe T; Enomoto Y; Onitsuka T
    Anticancer Res; 2007; 27(4C):3001-4. PubMed ID: 17695486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
    Shimada H; Oohira G; Okazumi S; Matsubara H; Nabeya Y; Hayashi H; Takeda A; Gunji Y; Ochiai T
    J Am Coll Surg; 2004 May; 198(5):737-41. PubMed ID: 15110807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of interstitial lung disease on survival for patients with non-small cell lung cancer.
    Miyazaki K; Satoh H; Kurishima K; Nakamura R; Ishikawa H; Kagohashi K; Ohara G; Hizawa N
    Anticancer Res; 2009 Jul; 29(7):2671-4. PubMed ID: 19596944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
    Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
    Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
    Maione P; Rossi A; Di Maio M; Gridelli C
    Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
    Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer].
    Boddu P; Villlines D; Aklilu M
    Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):725-730. PubMed ID: 27866514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytosis has a negative prognostic value in lung cancer.
    Maráz A; Furák J; Varga Z; Kahán Z; Tiszlavicz L; Hideghéty K
    Anticancer Res; 2013 Apr; 33(4):1725-9. PubMed ID: 23564823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia-leukocytosis syndrome associated with lung cancer.
    Hiraki A; Ueoka H; Takata I; Gemba K; Bessho A; Segawa Y; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
    Lung Cancer; 2004 Mar; 43(3):301-7. PubMed ID: 15165088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia.
    Werynska B; Ramlau R; Podolak-Dawidziak M; Jankowska R; Prajs I; Usnarska-Zubkiewicz L; Kuliczkowski K
    Neoplasma; 2003; 50(6):447-51. PubMed ID: 14689068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognostic value of thrombocytosis in patients with primary lung cancer].
    Pedersen LM; Milman N
    Ugeskr Laeger; 1998 Jun; 160(26):3917-20. PubMed ID: 9656833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
    Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
    J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy.
    d'Amato TA; Pettiford BL; Schuchert MJ; Parker R; Ricketts WA; Luketich JD; Landreneau RJ
    Ann Surg Oncol; 2009 Oct; 16(10):2848-55. PubMed ID: 19609620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.